ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 175 out of 2680

$513K Total Retail Price of All Prescriptions

Rank: 338 out of 2680

508 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,970 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 511 379 1 1
LEVOTHYROXINE SODIUM 386 310 2 4
OMEPRAZOLE 346 247 3 2
RAMIPRIL 291 240 4 49
PRAVASTATIN SODIUM 263 233 5 16
LOSARTAN POTASSIUM 240 190 6 18
LISINOPRIL 223 198 7 5
FUROSEMIDE 213 197 8 7
ATENOLOL 201 178 9 14
AMLODIPINE BESYLATE 195 176 10 3
METFORMIN HCL 190 149 11 6
ATORVASTATIN CALCIUM 166 160 12 10
WARFARIN SODIUM 153 106 13 12
RANITIDINE HCL 146 108 14 35
ALLOPURINOL 140 112 15 42
HYDROCHLOROTHIAZIDE 135 116 16 9
ALENDRONATE SODIUM 128 94 17 20
CARVEDILOL 125 105 18 27
POTASSIUM CHLORIDE 121 103 19 29
CITALOPRAM HBR 119 102 20 22
HYDROCODONE-ACETAMINOPHEN 114 100 S3 21 13
LEVOCETIRIZINE DIHYDROCHLORIDE 113 112 22 344
METOPROLOL SUCCINATE 112 112 23 11
SERTRALINE HCL 110 72 24 23
PREDNISONE 110 96 24 45
ZOLPIDEM TARTRATE 108 100 26 17
SPIRIVA 98 91 27 36
DONEPEZIL HCL 96 96 28 28
TRAMADOL HCL-ACETAMINOPHEN 88 86 29 167
GABAPENTIN 82 62 30 21
ADVAIR DISKUS 74 62 31 32
CRESTOR 71 64 32 15
PANTOPRAZOLE SODIUM 70 54 33 44
TAMSULOSIN HCL 69 66 34 25
METOPROLOL TARTRATE 69 54 34 8
NIASPAN 69 57 34 120
PEN NEEDLE 67 58 37 155
NEXIUM 64 49 38 19
NAMENDA 64 64 38 43
BISOPROLOL FUMARATE 63 56 40 163
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 57 40 117
LANTUS SOLOSTAR 62 50 42 68
TERAZOSIN HCL 60 59 43 141
MUPIROCIN 60 45 43 152
TRAMADOL HCL 57 53 45 33
PAROXETINE HCL 57 40 45 62
METFORMIN HCL ER 57 54 45 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.